Abstract:Sustained stress leads to series of changes in the brain, firstly through the activation of hypothalamus–pituitary–adrenal (HPA) axis and sympathetic nervous system (SNS) axis, then the release of glucocorticoid (GCs) and catecholamines (CAs), respectively. The circulating GCs can cause neuronal injury and even the loss of neurons, accompanying the increased level of proinflammatory cytokines in the circulation. Chronic stress has been linked to various diseases, especially mood disorders and neuropsychiatric disorders, mainly mediated by the limbic system. Yet the relationship between chronic stress and neurodegenerative disorders such as Alzheimer disease (AD) and Parkinson’s disease (PD) is unknown. It has been found that depression often precedes PD symptoms in clinical subjects [1], while many PD patients present with depression symptoms as well [2,3]. A recent study published in Molecular Psychiatry by Hemmerle et al. [4] addressed this point by subjecting 6-OHDA-lesioned rats to the chronic stress, and they found that chronic stress exacerbates the loss of dopamine neurons induced by 6-OHDA injection. The results strongly argued that chronic stress may function as an important factor in the development of PD and potentially other neurodegenerative diseases. Hemmerle et al. generated a rat model of PD by unilateral 6-OHDA injection, which produces selective toxicity to dopamine neurons, especially in substantia nigra. The dopamine neuron loss leads to motor behavior deficits, as reflected by the forelimb asymmetry test, because the loss of dopamine neurons would lead to impaired usage of the contralateral limb, while the severity of dopamine neuron loss was histologically examined by TH staining [4]. When the rats were subjected to chronic unpredictable stress, the authors found that the rats would demonstrate increased forelimb asymmetry (suggestive of worse behavior), which correlated with increased dopamine neuron loss (decreased TH staining). Interestingly, the chronic stress alone did not induce loss of dopamine neurons, and the stress had to occur simultaneously with toxin exposure [4], suggesting that the stress might act adjuvantly with the toxin or increase the vulnerability of the neurons. In clinical studies, depression as the most common disease caused by chronic stress may occur prior to PD symptoms [1] and may indicate worse prognosis for PD patients [5]. Yet it should be noted that the loss of dopamine neurons could occur much earlier to the motor symptoms [6] and therefore may be concurrent with the depression as well. What are the potential mechanisms linking stress and increased dopamine neuron loss? It is possible that glucocorticoid contributes to this process, partly through the glucocorticoid receptors (GRs) on the microglia, because MPTP-induced neurotoxicity was less in mice whose GRs were knocked down selectively on microglial cells [7]. In addition, GRs on dopamine neurons regulate the activity of the cells and might sensitize the neurons through excitotoxicity [8]. On the other hand, there is evidence suggesting that the depression can be caused by loss of dopaminergic innervation during PD progression [2], acting as the downstream of PD pathology. It is believed that the mesolimbic and mesocortical dopaminergic pathways that are disrupted in PD would contribute to the depression symptoms [3]. Indeed, a recent study has shown that selective activation of midbrain dopamine neurons with optogenetic tech-

Membrane phospholipid peroxidation promotes loss of dopaminergic neurons in psychological stress‐induced Parkinson's disease susceptibility

Effect of intraperitoneal pentobarbital injection or isoflurane inhalation anesthesia on the rat acute stress response

Chronic Stress and Parkinson's Disease

Stress Increases MHC-I Expression in Dopaminergic Neurons and Induces Autoimmune Activation in Parkinson's Disease

NOX4 Exacerbates Parkinson’s Disease Pathology by Promoting Neuronal Ferroptosis and Neuroinflammation

Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease

Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease.

The Effects of Stress on Lewy Pathology in Dopamine Neurons

Chronic mild stress accelerates the progression of Parkinson's disease in A53T α-synuclein transgenic mice

Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson's disease with emotional stress

Ginsenoside Rg1 ameliorates stress-exacerbated Parkinson's disease in mice by eliminating RTP801 and α-synuclein autophagic degradation obstacle

Oxidative stress factors in Parkinson’s disease

Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson's Disease

Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis

Early-Life Stress Induces Prodromal Features of Parkinsonism in Ageing Rats.

Regulation of hepatocyte phospholipid peroxidation signaling by a Chinese patent medicine against psychological stress-induced liver injury

Stress-induced precocious aging in PD-patient iPSC-derived NSCs may underlie the pathophysiology of Parkinson's disease

Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson’s Disease

Oxidative stress and regulated cell death in Parkinson’s disease

Midbrain dopamine oxidation links ubiquitination of glutathione peroxidase 4 to ferroptosis of dopaminergic neurons

ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis